Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma

NCT07302516 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

NCT05274815 ·Status: COMPLETED ·Phase: PHASE3

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

NCT03706079 ·Status: COMPLETED ·Phase: PHASE3

Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain

NCT06487065 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

NCT03406078 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

NCT03927157 ·Status: COMPLETED ·Phase: PHASE3

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

NCT06473779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Tezepelumab PRO Study

NCT05922891 ·Status: COMPLETED

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT07013760 ·Status: COMPLETED

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma

NCT03347279 ·Status: COMPLETED ·Phase: PHASE3

Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

NCT06455462 ·Status: COMPLETED

Tezepelumab Home Use Study

NCT03968978 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma

NCT04048343 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma

NCT05062759 ·Status: COMPLETED ·Phase: PHASE3

REVErsing Airway Remodelling With Tezepelumab

NCT05651841 ·Status: RECRUITING ·Phase: PHASE3

The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

NCT06666504 ·Status: NOT_YET_RECRUITING

Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma

NCT01405963 ·Status: COMPLETED ·Phase: PHASE1

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

NCT05398263 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma

NCT04673630 ·Status: COMPLETED ·Phase: PHASE1

A Study for Observing Severe Asthma in Patients Treated With Tezepelumab

NCT05677139 ·Status: COMPLETED

Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

NCT06948396 ·Status: ACTIVE_NOT_RECRUITING

Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma

NCT05280418 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects

NCT03989544 ·Status: COMPLETED ·Phase: PHASE1

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

NCT00398645 ·Status: COMPLETED ·Phase: PHASE2

Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma

NCT05740748 ·Status: UNKNOWN ·Phase: PHASE2